Af­ter decades in Big Phar­ma, Kel­ly Page heads to 'growth stage'; Al­lied with No­var­tis, Bi­cy­cle se­lects de­vel­op­ment chief

Fol­low­ing a decades-long ca­reer in Big Phar­ma, Kel­ly Page want­ed to use her re­search and com­mer­cial ex­pe­ri­ence to help a small com­pa­ny grow.

Last Tues­day, she start­ed at Arv­inas, a Pfiz­er-part­nered biotech look­ing to har­ness the body’s pro­tein dis­pos­al sys­tem to de­grade dis­ease-caus­ing pro­teins. She has tak­en the role of se­nior VP and glob­al head of on­col­o­gy strat­e­gy and pro­gram lead­er­ship, a field that’s mo­ti­vat­ed her per­son­al­ly since three close rel­a­tives were di­ag­nosed with lym­phoma in 1999.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER